title: Serbian lymphoma study group: demografic characteristics of 257 patients with follicular lymphoma.
abstract: OBJECTIVE
  Follicular lymphoma (FL) is a B-cell tumor usually with indolent clinical course, yet in some cases the course of the disease can be very aggressive. The aim of the research was to determine distribution of patients into prognostic groups based on the International Prognostic Index (IPI) and Folicular Lymphoma International Prognostic Index (FLIPI) criteria, as well as to determine the importance of classifying patients into the prognostic groups, since this could potentially have the influence on selection of the treatment modality.
  
  
  METHODS
  The retrospective study was performed on 257 patients with follicular lymphoma diagnosed between January 2000 and April 2011.
  
  
  RESULTS
  Based on the IPI score, 153 (59.53%) patients had low risk, 57 (22.18%) low intermediate risk, 15 (5.84%) high intermediate risk, 9 (3.50%) high risk, whereas the classification of 23 patients diagnosed with FL remained with unknown risk according to the IPI. Based on the FLIPI prognostic index, 113 (43.97/6) patients had low risk, 70 (27.24%) intermediate risk and 51 (19.84%) high risk, whereas the classification of 23 (8.95%) patients remained unknown. On the basis of the FLIPI 2 prognostic index, 48 (18.68%) patients had low risk, 145 (56.42%) intermediate risk and 41 (15.95%) high risk. The classification into prognostic groups for 23 (8.95%) patients remained unknown. According to the IPI, FLIPI and FLIPI 2 there were the patients that required treatment in all the risk groups.
  
  
  CONCLUSIONS
  The FLIPI and FLIPI 2 effectively identify patients at high risk, thus helping in treatment decision for each single patient.
authors.forename: Olivera
authors.initials: O
authors.lastname: Simonović
authors.forename: Lana
authors.initials: L
authors.lastname: Mačukanović-Golubović
authors.forename: Boško
authors.initials: B
authors.lastname: Andjelić
authors.forename: Darko
authors.initials: D
authors.lastname: Antić
authors.forename: Biljana
authors.initials: B
authors.lastname: Mihaljević
mesh_terms: D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000145:classification / Q000453:epidemiology*; D008297:Male; D011379:Prognosis; D012189:Retrospective Studies; D055771:Serbia / Q000453:epidemiology